Fairtility, an AI innovator, has announced that Esco Medical has selected CHLOE EQ as the AI decision support tool to integrate with its MIRI® Time-Lapse Incubators (TLI). CHLOE EQ will provide its transparent AI embryo quality assessment capabilities, enabling explainable AI output to recommend embryos most likely to lead to implantation in an IVF cycle. The commercial collaboration will provide a joint offering of the MIRI® TLI with CHLOE EQ integrated with the MIRI server, which will reduce time spent on manual annotation by an average of 33 percent per cycle, resulting in up to a 50 percent increase of available time for embryologists.
